Mayor Eric Adams announces seizure of 1200 pounds of illegal e-cigarettes

Oct.18.2024
Mayor Eric Adams announces seizure of 1200 pounds of illegal e-cigarettes
Mayor Eric Adams announced the seizure of over 1200 pounds of illegal e-cigarette products in NYC for destruction.

According to a report from Audacy on October 17, New York City Mayor Eric Adams announced on that day that over 1200 pounds of illegal e-cigarette products have been seized and are currently being prepared for transport out of New York City for destruction. The products to be destroyed include several well-known e-cigarette brands such as YOOZ and AIR BAR.

Mayor Eric Adams announces seizure of 1200 pounds of illegal e-cigarettes
The products in this batch to be destroyed include several well-known e-cigarette brands such as YOOZ, AIR BAR, etc. | Image source: X official website


The seized products by the task force contain batteries and other hazardous materials that require safe handling. The products will be sent to ENP Environmental, a long-term DNA evidence destruction supplier for the New York Police Department (NYPD), located in Ohio, for processing.

Mayor Eric Adams announces seizure of 1200 pounds of illegal e-cigarettes
Mayor Adams speaks out on his social media | Image source: X official website


As of now, the City of New York has seized illegal goods worth over 80 million US dollars (61.44 million pounds) in this operation, which are taking up too much space in the NYPD evidence warehouse. In August of this year, the task force destroyed over four tons of illegal marijuana products, as part of the standard procedure for disposing of illegal items by the NYPD.


On October 16th, Mayor Adams announced on his social media platform X that a total of 1200 pounds of illegal e-cigarettes have been seized. He stated, "These dangerous, unregulated, and untaxed products are just a small portion of what has been confiscated as part of the 'Operation Lockdown' initiative." He added that the crackdown on these illicit products is still ongoing.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
VEIIK VITO: A Masterpiece in Your Palm, Crafted for the Extraordinary
VEIIK VITO: A Masterpiece in Your Palm, Crafted for the Extraordinary
Jun.18
UK Vape Juice Brand Riot Labs Launches Six New Flavors with Multiple Nicotine Strengths of 5, 10, and 20mg
UK Vape Juice Brand Riot Labs Launches Six New Flavors with Multiple Nicotine Strengths of 5, 10, and 20mg
BAT Japan will release a limited edition glo HYPER pro HANABI EDITION on July 25th to celebrate the conclusion of their "Live Life in Color" brand event in 2025. Designed by Motty, the device features a vibrant summer fireworks theme. From July 25th to 27th, a cozy glo™ HANABI tobacco lounge will be set up at the FUJI ROCK FESTIVAL, showcasing the unique design.
Jul.23 by 2FIRSTS.ai
North Carolina Enforces Comprehensive E-Cigarette Regulations: Unlisted Products Banned Starting July
North Carolina Enforces Comprehensive E-Cigarette Regulations: Unlisted Products Banned Starting July
Starting July 1, 2025, North Carolina will ban the sale of e-cigarettes and related products not listed in the state’s official product directory. Violations may lead to fines up to $10,000 per product, license suspension, and product destruction.
Jul.01 by 2FIRSTS.ai
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Since April 2024, Singapore’s Health Sciences Authority (HSA) has shut down over 600 Telegram groups promoting or selling e-cigarettes and Kpods. This is the first time HSA has released such data. Additionally, from January 2024 to March 2025, HSA and the Ministry of Health removed more than 6,800 online listings related to e-cigarettes—more than double the number removed in 2023.
Jul.17 by 2FIRSTS.ai
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
On July 22, Philip Morris International (PMI) reported Q2 2025 earnings with net revenue of $10.14 billion, up 7.1% year-over-year. Smoke-free product revenue reached $4.2 billion (41% of total), growing 14.5% organically. Heated tobacco shipments hit 38.8 billion units; e-vapor shipments more than doubled; nicotine pouch volume rose 43.3%. IQOS market share in Japan climbed to 31.7%. PMI raised its full-year EPS guidance to $7.24–$7.37.
Jul.22